Mizuho reiterated its bullish stance on biotech Neumora Therapeutics Inc. on Wednesday, and predicted a positive outcome when the company reports data from a late-stage trial of its treatment for ...

Clene (NASDAQ: CLNN) reported its Q3 2024 financial results and provided updates on its CNM-Au8 programs. Key operational highlights included a recent FDA meeting to discuss the potential for ...

Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, announced ...

Leerink Partners analyst Lili (Aurélie) Nsongo has reiterated their bullish stance on VYGR stock, giving a Buy rating yesterday.

Why this news will impact the lives of people affected by Alzheimer's disease: The first disease-modifying therapies for ...

It plays a key role in the body's acute (short-term) stress response by triggering the sympathetic nervous system ... heart disease, diabetes, hyperthyroidism (overactive thyroid), depression, asthma, ...

In a new study, researchers at McMaster University have identified a potential treatment for Sandhoff and Tay-Sachs ...

Gabapentinoids -- pregabalin and gabapentin -- were tied to increased hip fracture risk in older adults. Gabapentinoids -- ...

In a research trial published Wednesday in the scientific journal Nature, Drew was the only one of 11 patients with DIPG and a related cancer to show such a phenomenal success. But the fact that it's ...

Statistics vary by source, but last year there were a record-high 650,100 homeless people in the United States, many of them ...

My father was rocketed and shot at in Southeast Asia and came home a bomb waiting to explode. His nervous system was ...